Results 151 to 160 of about 4,986,038 (258)

Association of Valvular Disease Progression Using Echocardiographic Findings in a Large U.S. Cohort. [PDF]

Echocardiography
Bautista Neughebauer AA, Yehya A, Benza RL, Talreja D.   +3 more
europepmc   +1 more source

Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank. [PDF]

Open Heart, 2022
Tung M, Nah G, Tang J, Marcus G, Delling FN.   +4 more
europepmc   +1 more source

Purification of Disassembled Capsid Protein by Hydroxyapatite Chromatography Enhances Virus‐Like Particle Recovery

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Virus‐like particles (VLPs) are a promising modality with extensive applications in prophylactic and therapeutic vaccine design. Human Papillomavirus (HPV) vaccines are one such example where VLP vaccine applications have led to the successful reduction in HPV‐associated diseases, such as cervical cancer.
Nicholas Samuelson, Nathaniel Parker, Shiyi Wang, Sara Daley, Aaron Cote, Michael A. Winters   +5 more
wiley   +1 more source

When a Cardiac Tumor Mimics Valvular Disease: Giant Left Atrial Myxoma Causing Functional Mitral Stenosis. [PDF]

Cureus
Rodríguez Sánchez MA, Cortés Sáinz A, González Carrillo DA, Lugo Picos HA, Zamora Carrasco MG, Garduño Felix DD, Najera Lopez J, Nieto Morga PA.   +7 more
europepmc   +1 more source

A lightweight hybrid deep learning system for cardiac valvular disease classification. [PDF]

Sci Rep, 2022
Al-Issa Y, Alqudah AM.
europepmc   +1 more source

Hyperbranched poly‐L‐lysine surface‐engineered bioprosthetic heart valves with anti‐calcification, anti‐infection, and durability

BMEMat, EarlyView.
The challenges of bioprosthetic heart valves (BHV) with respect to calcification, infection, and poor durability are tackled by surface engineering of hyperbranched poly‐L‐lysine (HBPL), providing a translational solution to improve long‐term valve performance.
Pai Peng, Dongchao Qiu, Yongyuan Kang, Qiaoxuan Wang, Xuelong Wang, Boyana Parvanova, Miroslav Karabaliev, Changyou Gao   +7 more
wiley   +1 more source

TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease-a Case Series. [PDF]

CASE (Phila)
Vasquez-Rodriguez JF, Lemus-Barrios G, Rangel-Rivera D, Garnica-Sepulveda V, Avila Y, Medina-Mur R, Perez-Fernandez OM, Holguín-Riaño D, Salazar-Castro G, Dueñas-Criado K.   +9 more
europepmc   +1 more source

Prospective cohort study of characteristics and sex differences in elderly patients with degenerative valvular disease. [PDF]

BMJ Open, 2022
Qi X, Xu H, Liu Q, Ye Y, Wu Y, CHINA-DVD Collaborators.   +5 more
europepmc   +1 more source

Purification and concentration of model viruses using single‐pass tangential flow filtration

Biotechnology Progress, EarlyView.
Single‐pass TFF was developed for an enveloped and non‐enveloped virus for use in continuous downstream purification processes. Enveloped virus was concentrated and purified. Abstract The vaccine and viral vector industry is growing at an accelerated rate.
Luis Alberto Mejía‐Manzano, Lynn Manchester, Grace Wallis, Kan Wang, Bruce P. Lee, Michael Betenbaugh, Caryn L. Heldt   +6 more
wiley   +1 more source

Clarifying the Scope of Native EHRA Type 2 Valvular Disease and Event Reporting in Anticoagulated Patients With Atrial Fibrillation. [PDF]

Clin Cardiol
Chen J, Xu M.
europepmc   +1 more source